 modality therapy advanced non-small cell lung carcinoma Multi-modality treatment cisplatin chemotherapy external beam radiation patients advanced Stage III non-small cell lung carcinoma regimen preoperative fashion cycles patients resectable curative intent cycles remainder patients clinical response rate entire group overall local control rate median survival months median follow-up live patients months actuarial survival disease-free survival rates Histologic complete response survival actuarial survival disease-free survival rates resected patients complete histologic responders disease-free survival pattern first recurrence histology presence lymph nodes subset patients actuarial survival disease-free survival rates inoperable patients cycles treatment local control majority patients Stage IIIB disease Mountain International system operability local recurrence survival concomitant treatment regimen feasible major toxicities leukopenia nausea vomiting